Strategies for the Development of Vaccines for Typhoid Fever, Shigellosis, and Cholera

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Annals of the New York Academy of Sciences

• Publication date

  1989-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1749-6632.1989.tb27365.xPMID 2698084
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Broad-host-range vectors for delivery of TnphoA: use in genetic analysis of secreted virulence determinants of Vibrio cholerae

  1989cited by this paper
• Coordinate regulation and sensory transduction in the control of bacterial virulence.

  1989cited by this paper
• A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence.

  1989cited by this paper
• A Salmonella locus that controls resistance to microbicidal proteins from phagocytic cells.

  1989cited by this paper
• Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques

  1988cited by this paper
• Safe, live Vibrio cholerae vaccines?

  1988cited by this paper
• Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans

  1988cited by this paper
• Development of an auxotrophic oral live Shigella flexneri vaccine.

  1988cited by this paper
• Pertussis toxin S1 mutant with reduced enzyme activity and a conserved protective epitope.

  1988cited by this paper
• Evidence that glutamic acid 167 is an active-site residue of Shiga-like toxin I.

  1988cited by this paper
• Auxotrophic Salmonella typhi as live vaccine.

  1988cited by this paper
• A galE via (Vi antigen-negative) mutant of Salmonella typhi Ty2 retains virulence in humans

  1988cited by this paper
• Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin.

  1987cited by this paper
• Cholera toxin transcriptional activator toxR is a transmembrane DNA binding protein.

  1987cited by this paper
• Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation.

  1987cited by this paper
• Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic

  1987cited by this paper
• Live oral Salmonella vaccines: potential use of attenuated strains as carriers of heterologous antigens to the immune system

  1987cited by this paper
• Conserved domains in bacterial regulatory proteins that respond to environmental stimuli.

  1987cited by this paper
• Characteristics of humoral and cellular immunity to Salmonella typhi in residents of typhoid-endemic and typhoid-free regions.

  1987cited by this paper
• Incidence of salmonellosis in patients with AIDS.

  1987cited by this paper
• Nucleotide sequence of the Shiga-like toxin genes of Escherichia coli.

  1987cited by this paper
• A twenty-five year review of laboratory-acquired human infections at the National Animal Disease Center.

  1987cited by this paper
• Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans.

  1987cited by this paper
• Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report.

  1987cited by this paper
• Summary of an international workshop on typhoid fever.

  1986cited by this paper
• Covalent modification of the glnG product, NRI, by the glnL product, NRII, regulates the transcription of the glnALG operon in Escherichia coli.

  1986cited by this paper
• DEFENSINS: NATURAL PEPTIDE ANTIBIOTICS IN HUMAN NEUTROPHILS

  1986cited by this paper
• Nucleotide sequence of the phoR gene, a regulatory gene for the phosphate regulon of Escherichia coli.

  1986cited by this paper
• Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent.

  1986cited by this paper
• TnphoA: a transposon probe for protein export signals.

  1985cited by this paper
• Positive control of a regulon for defenses against oxidative stress and some heat-shock proteins in Salmonella typhimurium.

  1985cited by this paper
• Primary characterization of the protein products of the Escherichia coli ompB locus: structure and regulation of synthesis of the OmpR and EnvZ proteins

  1985cited by this paper
• Construction of a potential live oral bivalent vaccine for typhoid fever and cholera-Escherichia coli-related diarrheas

  1984cited by this paper
• Safety and antigenicity of typhoid-Shigella sonnei vaccine (strain 5076-1C).

  1984cited by this paper
• Vi serology in detection of chronic Salmonella typhi carriers in an endemic area.

  1983cited by this paper
• Salmonella typhimurium infection in calves: protection and survival of virulent challenge bacteria after immunization with live or inactivated vaccines

  1983cited by this paper
• Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine development

  1983cited by this paper
• Characteristics of the attenuated oral vaccine strain "S. typhi" Ty 21a.

  1983cited by this paper
• Construction of a potential bivalent vaccine strain: introduction of Shigella sonnei form I antigen genes into the galE Salmonella typhi Ty21a typhoid vaccine strain

  1981cited by this paper
• Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines

  1981cited by this paper
• Regulation of nonspecific acid phosphatase in Salmonella: phoN and phoP genes

  1979cited by this paper
• Natural resistance to Salmonella typhimurium in different inbred mouse strains.

  1979cited by this paper
• [Salmonella infections].

  1977cited by this paper
• Evaluation of a UDP-glucose-4-epimeraseless mutant of Salmonella typhi as a liver oral vaccine.

  1977cited by this paper
• Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine.

  1975cited by this paper
• THE ROUTE OF ENTERIC INFECTION IN NORMAL MICE

  1974cited by this paper
• Immunity in Experimental Salmonellosis III. Comparative Immunization with Viable and Heat-Inactivated Cells of Salmonella typhimurium

  1972cited by this paper
• Comparative Immunogenicity of Heat-Killed and Living Oral Salmonella Vaccines

  1972cited by this paper
• Immunity in Experimental Salmonellosis II. Basis for the Avirulence and Protective Capacity of gal E Mutants of Salmonella typhimurium

  1971cited by this paper
• Immunity in typhoid fever: evaluation of live streptomycin-dependent vaccine.

  1970cited by this paper
• Typhoid fever: pathogenesis and immunologic control.

  1970cited by this paper
• Immunity in Experimental Salmonellosis I. Protection Induced by Rough Mutants of Salmonella typhimurium

  1970cited by this paper
• On the localization of alkaline phosphatase and cyclic phosphodiesterase in Escherichia coli.

  1968cited by this paper
• A seven-year field trial of two typhoid vaccines in Guyana.

  1967cited by this paper
• Controlled field trials and laboratory studies on the effectiveness of typhoid vaccines in Poland, 1961-64.

  1966cited by this paper
• MECHANISMS OF ACQUIRED RESISTANCE IN MOUSE TYPHOID

  1966cited by this paper
• A CONTROLED FIELD TRIAL OF THE EFFECTIVENESS OF ACETONE-DRIED AND INACTIVATED AND HEAT-PHENOL-INACTIVATED TYPHOID VACCINES IN YUGOSLAVIA.

  1964cited by this paper
• The effects of biochemical mutation on the virulence of Bacterium typhosum; the loss of virulence of certain mutants.

  1951cited by this paper

• Characterization of defined ompR mutants of Salmonella typhi: ompR is involved in the regulation of Vi polysaccharide expression

  1994cites this paper
• Cholera in the Americas. Guidelines for the clinician.

  1992cites this paper
• PAPERS BY AUTHOR

  1992cites this paper